Taysha Gene Therapies Inc Capital Reinvestment Ratio
Taysha Gene Therapies Inc capital reinvestment ratio. Taysha Gene Therapies Inc (TSHA) has a Capital Reinvestment Ratio of 0.16x as of December 2022, meaning it reinvests 0% of its operating cash flow ($14.28 Million) in capital expenditures ($2.31 Million). See Taysha Gene Therapies Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Taysha Gene Therapies Inc (2019–2019)
Capital reinvestment ratio of Taysha Gene Therapies Inc from 2019 to 2019. This chart tracks Taysha Gene Therapies Inc's Capital Reinvestment Ratio across 1 annual periods. See financial agility of Taysha Gene Therapies Inc to measure the company's free cash flow as a share of total liabilities.
Taysha Gene Therapies Inc Capital Reinvestment Ratio by Year (2019–2019)
Taysha Gene Therapies Inc capital reinvestment ratio by year from 2019 to 2019. For the full cash flow conversion analysis, see TSHA cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.61x | $135.00K | $82.00K | — |